Goran Micevic, MD, PhD, instructor in dermatology, is one of 25 recipients of the American Society for Clinical Investigation Emerging-Generation Award. The award recognizes Dr. Micevic’s outstanding dedication and contributions to dermatologic research as an early career physician-scientist.
Founded in 1908, the ASCI is a medical honor society that represents more than 3,000 members. Its mission is to bolster the research, education, and clinical endeavors of physician-scientists by promoting collegiality among a diverse pool of members and recognizing and supporting the development of emerging physician-scientists. ASCI members have made seminal contributions to science and medicine and include 23 Nobel Laureates and many National Academy inductees.
Dr. Micevic is a member of the Flavell Lab within Yale’s Immunobiology department, which studies the basic principles of innate and adaptive immune responses, including those underpinning the body’s immune response against cancer.
Through the career development opportunities, peer networking, and research discussions made available through the Award, he aims to advance his primary research focus, studying the interaction between immune cells and cancer cells in the skin, as his career progresses.
Said Dr. Micevic, “Understanding the molecular interactions between T-cells and melanoma cells can help answer why some patients have durable responses to immunotherapy, while others experience disease recurrence.”
The Award enables Dr. Micevic not only to advance fundamental studies on T-cell epigenetics and immunologic memory, but ultimately to improve patient outcomes.
“As dermatologists, we have a keen appreciation of the immune system’s critical role in preventing skin cancers and are at the forefront of managing the complex interactions between immune cells and the skin seen with immunotherapies…This award supports my commitment to investigative dermatology to develop better treatment for our patients.”